After being on the sidelines for a few months, a major US investment bank has won back key financial advisory business with Samsung, industry sources said, Thursday. “JPMorgan was included as one of the financial advisors with other leading international banks on the initial public offering (IPO) of Samsung BioLogics,” one source said.
